30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Espisurf Announces Hong Kong Distribution, U.S. Subsidiary -

Episurf Medical entered a distribution agreement with Pacific Medical Systems in Hong Kong, its first market in China, and established a U.S. subsidiary to conduct clinical studies in support of its regulatory path. Per the company's 2017 year-end report, an Investigational Device Exemption clinical trial is planned in U.S. and European centers for Episealer knee implants and will be part of a premarket approval application to FDA. (Episurf Medical AB, 4/26/18)